Annals of Nuclear Medicine

, Volume 9, Issue 3, pp 137–142 | Cite as

Brain uptake and metabolism of [1-11C]octanoate in rats: Pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism

  • Yuji Kuge
  • Kazuyoshi Yajima
  • Hidefumi Kawashima
  • Hiroyoshi Yamazaki
  • Naoto Hashimoto
  • Yoshihiro Miyake
Original Article


The uptake of octanoate in rat brain and its metabolism were investigated by means of intravenously injecting [1-11C] or [1-14C]octanoate as a tracer. The radioactivity in the cerebrum was increased by an injection of [1-11C]octanoate, and reached its peak level (0.33% ID/g) in about 2 to 5 min, and then decreased slowly. The cerebrum-to-blood ratio of the radioactivity increased with time over a period of 30 min. At 30 sec, [ 1-11C]octanoate that remained unchanged in the cerebrum accounted for only 8% of the total radioactivity, in spite of there being about 90% in the blood. By means of an injection of [ 1-14C]octanoate, more than 70% of the total radioactivity in the cerebrum was found to be attributable to radiolabeled glutamate and glutamine at each time point measured between 30 sec and 30 min. The results show that [1-11C]octanoate enters rat brain easily and is trapped in the cerebrum, probably in the form of glutamate and glutamine, and the usefulness of [ 1-11C] octanoate as a radiopharmaceutical for studying brain fatty acid metabolism by positron emission tomography is therefore suggested.

Key words

[1-11C]octanoate radiopharmaceutical brain metabolism rat 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sokoloff L, Fitzgerald GG, Kaufman EE. Cerebral nutrition and energy metabolism.In Nutrition and the Brain, vol. 1 (Wurtman RJ, Wurtman JJ, eds.), New York, Raven Press, pp. 87–139, 1977.Google Scholar
  2. 2.
    Reichmann H, Maltese WA, De Vivo DC. Enzymes of fatty acid j3-oxidation in developing brain.J Neurochem 51: 339–344, 1988.PubMedCrossRefGoogle Scholar
  3. 3.
    Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues.Physiol Rev 60: 143–187, 1980.PubMedGoogle Scholar
  4. 4.
    Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture.JNeurochem 56: 1376–1386, 1991.CrossRefGoogle Scholar
  5. 5.
    Edmond J. Energy metabolism in developing brain cells.Can J Physiol Pharmacol 70: S118–129, 1992.PubMedGoogle Scholar
  6. 6.
    Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidati ve metabolism by neurons, astrocytes and oligodendrocytes from developing brain in primary culture.J Neurosci Res 18: 551–561, 1987.PubMedCrossRefGoogle Scholar
  7. 7.
    Oldendorf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids.Am J Physiol 224: 1450–1453, 1973.PubMedGoogle Scholar
  8. 8.
    Spector R. Fatty acid transport through the blood-brain barrier.J Neurochem 50: 639–643, 1988.PubMedCrossRefGoogle Scholar
  9. 9.
    Cremer JE, Teal HM, Heath DF, Cavanagh JB. The influence of portocaval anastomosis on the metabolism of labeled octanoate, butyrate and leucine in rat brain.J Neurochem 28: 215–222, 1977.PubMedCrossRefGoogle Scholar
  10. 10.
    Rowley H, Collins RC. [1-14C]Octanoate: a fast functional marker of brain activity.Brain Res 335: 326–329, 1985.PubMedCrossRefGoogle Scholar
  11. 11.
    Winstead MB, Lamb JF, Winchell HS. Relationship of chemical structure toin vivo scintigraphic distribution patterns of11C compounds: I.11C-Carboxylates.J Nucl Med 14: 747–754, 1973.PubMedGoogle Scholar
  12. 12.
    Fowler JS, Gallagher BM, MacGregor RR, Wolf AP. Carbon-11 labeled aliphatic amines in lung uptake and metabolism studies: potential for dynamic measurementsin vivo.J Pharmacol Exp Ther 198: 133–145, 1976.PubMedGoogle Scholar
  13. 13.
    Pochapsky SS, VanBrocklin HF, Welch MJ, Katzenellenbogen JA. Synthesis and tissue distribution of fluorine-18 labeled trifluorohexadecanoic acids. Considerations in the development of metabolically blocked myocardial imaging agents.Bioconjugate Chem 1: 231–244, 1990.CrossRefGoogle Scholar
  14. 14.
    Nagatsugi F, Sasaki S, Maeda M. 8-[18F]Fluorooctanoic acid and its β-substituted derivatives as potential agents for cerebral fatty acid studies: synthesis and biodistribution.Nucl Med Biol 21: 809–817, 1994.PubMedCrossRefGoogle Scholar
  15. 15.
    Ishiwata K, Ishii K, Ogawa K, Sasaki T, Toyama H, Ishii S, et al. Synthesis and preliminary evaluation of [1-11C]hexanoate as a PET tracer of fatty acid metabolism.Ann Nucl Med 9: 51–57, 1995.PubMedCrossRefGoogle Scholar
  16. 16.
    Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain.Brain Research 161: 303–310, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Brown M, Marshall DR, Sobel BE, Bergmann SR. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.Circulation 76: 687–696, 1987.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Yuji Kuge
    • 1
  • Kazuyoshi Yajima
    • 1
  • Hidefumi Kawashima
    • 1
  • Hiroyoshi Yamazaki
    • 1
  • Naoto Hashimoto
    • 1
  • Yoshihiro Miyake
    • 1
  1. 1.Institute for Biofunctional Researchc/o National Cardiovascular CenterOsakaJapan

Personalised recommendations